Cancer-associated adipocytes (CAAs) are increasingly recognized as active and heterogeneous components of the tumor microenvironment. Initially defined as tumor-adjacent adipocytes characterized by lipid depletion, reduced expression of mature adipocyte markers, and inflammatory activation, CAAs are now understood to e...
Jin-Dong Xie, Ting-Ting Cai, Neng Wang et al.· Cancer Letters· 0 citations
TFE3‐rearranged renal cell carcinoma (TFE3‐rRCC) is uncommon and encompasses biologically diverse tumors, while evidence to guide systemic treatment remains sparse. We examined clinical outcomes, treatment patterns, and molecular features in a multicenter real‐world cohort.
Shu-Xuan Zhu, Si-Qi Zhou, Xi Tian et al.· Cancer Medicine· 0 citations
The pack-years analysis supported partial agreement between recent biomarker exposure and cumulative smoking history, but also showed that cotinine and pack-years capture different exposure dimensions.